Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tenofovir plus telbivudine versus tenofovir alone in HBeAg-positive chronic hepatitis B
ChiCTR-OPN-17012206Phase 4Not yet recruiting
- Sponsor
- People's Liberation Army 81 Hospital
- Start
- Sep 2017
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of tenofovir and telbivudine in Chronic Hepatitis B (CHB) (2 arms), sponsored by People's Liberation Army 81 Hospital. Primary endpoints: serum marker for hepatitis B and HBV DNA level. Planned start Sep 2017; status: not yet recruiting.
02
Drugs
tenofovirtelbivudine
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on ChiCTR-OPN-17012206.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPN-17012206.